Dupixent Lawyers of HLF A Division of The Hurwitz Law Firm PC · Lymphoma Attorneys

1st Circuit Dupixent News of MA, ME, NH, RI CTCL Cancer

1st Circuit Dupixent News headline featuring skin cancer cells

1st Circuit Dupixent news shows skin cancer cases across Maine, Massachusetts, New Hampshire, Rhode Island, and Puerto Rico. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims.

To learn more, please see our information on claiming a 1st Circuit Dupixent settlement.


Maine Dupixent News

Maine Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.

  • ME Dupixent News – Coming Soon / As Available

If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Maine Dupixent lawsuit.


Massachusetts Dupixent News

Massachusetts Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.

  • MA Dupixent News – Coming Soon / As Available

If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Massachusetts Dupixent lawsuit.


New Hampshire Dupixent News

New Hampshire Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.

  • NH Dupixent News – Coming Soon / As Available

If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a New Hampshire Dupixent lawsuit.


Rhode Island Dupixent News

Rhode Island Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.

  • RI Dupixent News – Coming Soon / As Available

If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Rhode Island Dupixent lawsuit.


1st Circuit Dupixent News Supports MDL Settlement for Skin Cancer

1st Circuit Dupixent news of T-cell lymphoma has raised concerns for eczema and asthma patients in Maine, Massachusetts, New Hampshire, Rhode Island, and Puerto Rico. As such, public support is growing for the court’s certification of a Dupixent Multi-District Litigation (MDL) to administer claims.


File Your 1st Circuit Dupixent Settlement Claim Here text on depiction of First Circuit court with syringe arm injection and high value cash backdrop.
1st Circuit Dupixent news of an MDL settlement for skin cancer in Maine, Massachusetts, New Hampshire, Rhode Island, or Puerto Rico.

Lymphoma Attorneys Act on 1st Circuit Dupixent News of Skin Cancer

Reporting skin cancer is an important first step to justice. If your family has been impacted by Dupixent, contact us about filing a 1st Circuit settlement claim.

For background information on T-cell lymphoma, please see our Dupixent lawyers homepage.